Riskpilot← Back to searchSign inGet full accessKLINIKK OPTIMAL TANANGER AS
ASActiveOrg 998601754Hammaren 23, 4056 TanangerTraditional, complementary and alternative medicine activities · NACE 8696Est. 20122 employees
Revenue 2024
NOK 9,3M
-5% vs 2023
EBITDA margin
0.7%
+19% vs 2023
Equity ratio
43.8%
Financial strength
Net profit 2024
NOK 140K
+19% vs 2023
| Revenue | NOK 9,3M | -5% |
| EBITDA | NOK 66K | +19% |
| Net profit | NOK 140K | +19% |
| Total assets | NOK 2,9M | -12% |
| Equity | NOK 1,3M | +12% |
| Employees | 2 | — |
Legal name
KLINIKK OPTIMAL TANANGER AS
Org number
998601754
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
9. juli 2012
Share capital
NOK 30 200
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Daglig leder alene.
Company purpose
Kiropraktor- og fysioterapiklinikk og alt som herved naturlig er forbundet, herunder å yte tjenester, selge produkter, drive treningssenter og lignende.
Address
Hammaren 23, 4056 Tananger
Phone
+4751663333
Email
post@klinikkoptimal.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 765 | 5 130 | 6 974 | 8 193 | 7 893 | 7 718 | 7 942 | 8 504 | 7 926 | 8 435 | 8 626 | 9 754 | 9 311 |
| Staff expenses | −1 | −361 | −478 | −592 | −588 | −686 | −702 | −855 | −689 | −679 | −658 | −792 | −685 |
| EBITDA | 19 | 359 | 1 166 | 345 | 269 | 134 | 364 | 187 | 167 | 86 | 79 | 56 | 66 |
| Depreciation & amort. | −56 | −182 | −226 | −230 | −213 | −216 | −162 | −92 | −63 | −52 | −63 | −61 | −57 |
| EBIT | −37 | 177 | 940 | 115 | 56 | −82 | 201 | 95 | 105 | 33 | 16 | −5 | 9 |
| Net financials | −21 | −54 | −52 | −29 | −19 | −14 | −15 | −2 | 4 | 80 | −62 | 123 | 136 |
| Profit before tax | −59 | 123 | 888 | 87 | 37 | −96 | 186 | 92 | 109 | 113 | −47 | 118 | 145 |
| Tax | −0 | 18 | 242 | 32 | 37 | 8 | 50 | 19 | 19 | 4 | 10 | −0 | 5 |
| Net profit | −59 | 105 | 646 | 55 | 0 | −104 | 137 | 73 | 89 | 109 | −57 | 118 | 140 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 205 | 1 606 | 2 802 | 2 403 | 2 654 | 2 112 | 2 830 | 2 944 | 2 940 | 2 882 | 3 269 | 3 319 | 2 920 |
| Equity | −34 | 71 | 717 | 772 | 773 | 669 | 806 | 879 | 968 | 1 077 | 1 020 | 1 138 | 1 278 |
| Long-term debt | 972 | 927 | 1 009 | 418 | 323 | 224 | 796 | 607 | 453 | 381 | 0 | 0 | 0 |
| Short-term debt | 267 | 609 | 1 075 | 1 213 | 1 558 | 1 219 | 1 229 | 1 458 | 1 519 | 1 424 | 2 249 | 2 180 | 1 641 |
| Total debt | 1 239 | 1 535 | 2 084 | 1 631 | 1 881 | 1 443 | 2 024 | 2 065 | 1 972 | 1 805 | 2 249 | 2 180 | 1 641 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20122024
Equity ratio
43.8%
This company
38.2%
Market median
+15% vs market
20122024
Return on equity
11.0%
This company
18.4%
Market median
+40% vs market
20122024
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20122024
Asset turnover
3.19×
This company
1.12×
Market median
+185% vs market
20122024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-07-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
HØ Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2022 | |
Kiropraktor Pettersen As | Company | 20.0% | 20.0% | 2024 |
| Individual | 20.0% | 20.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLINIKK OPTIMAL TANANGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christoffer Antonsen | Chief Executive Officer | 0 companies |
| Harald Øgård Todnem | Chief Executive Officer | 0 companies |
| Robert André Pettersen | Chairman | 0 companies |